NCT03836703View on ClinicalTrials.gov

Doubling the Iron Dose to Prevent IDA in Twin Pregnant Women

PHASE4CompletedINTERVENTIONAL
Enrollment

450

Participants

Timeline

Start Date

February 1, 2019

Primary Completion Date

July 1, 2020

Study Completion Date

August 1, 2020

Conditions
Hematologic Pregnancy Complications
Interventions
DRUG

Feroglobin single daily use

Feroglobin single daily use ( IRON FUM\&POLYSAC#1/FA/MV NO.18 162 Mg-115.2 Mg (106 Mg Iron)-1 Mg ORAL CAPSULE ) to prevent iron deficiency anemia during pregnancy from 14 weeks gestation going on.

DRUG

Feroglobin twice daily dose

Feroglobin twice daily dose ( IRON FUM\&POLYSAC#1/FA/MV NO.18 162 Mg-115.2 Mg (106 Mg Iron)-1 Mg ORAL CAPSULE ) to prevent iron deficiency anemia during pregnancy from 14 weeks gestation going on.

Trial Locations (1)

11311

Ahmed Abass, Cairo

All Listed Sponsors
lead

Ain Shams University

OTHER

NCT03836703 - Doubling the Iron Dose to Prevent IDA in Twin Pregnant Women | Biotech Hunter | Biotech Hunter